Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
BMC Neurosci ; 9: 80, 2008 Aug 12.
Artículo en Inglés | MEDLINE | ID: mdl-18700000

RESUMEN

BACKGROUND: Ample evidence suggests a substantial contribution of cellular and molecular changes in the spinal cord to the induction and persistence of chronic neuropathic pain conditions. While for a long time, proteases were mainly considered as protein degrading enzymes, they are now receiving growing interest as signalling molecules in the pain pathology. In the present study we focused on two cathepsins, CATS and CATX, and studied their spatiotemporal expression and activity during the development and progression of neuropathic pain in the CNS of the rat 5th lumbar spinal nerve transection model (L5T). RESULTS: Immediately after the lesion, both cathepsins, CATS and CATX, were upregulated in the spinal cord. Moreover, we succeeded in measuring the activity of CATX, which was substantially increased after L5T. The differential expression of these proteins exhibited the same spatial distribution and temporal progression in the spinal cord, progressing up to the medulla oblongata in the late phase of chronic pain. The cellular distribution of CATS and CATX was, however, considerably different. CONCLUSION: The cellular distribution and the spatio-temporal development of the altered expression of CATS and CATX suggest that these proteins are important players in the spinal mechanisms involved in chronic pain induction and maintenance.


Asunto(s)
Catepsinas/biosíntesis , Modelos Animales de Enfermedad , Regulación de la Expresión Génica/fisiología , Neuralgia/enzimología , Médula Espinal/enzimología , Animales , Catepsina K , Catepsinas/genética , Masculino , Neuralgia/genética , Neuralgia/patología , Dimensión del Dolor/métodos , Ratas , Ratas Wistar , Médula Espinal/patología
2.
J Vis Exp ; (113)2016 07 28.
Artículo en Inglés | MEDLINE | ID: mdl-27501318

RESUMEN

In this paper a protocol for the quick and standardized enrichment of leukocytes from small whole blood samples is described. This procedure is based on the hypotonic lysis of erythrocytes and can be applied to human samples as well as to blood of non-human origin. The small initial sample volume of about 50 to 100 µl makes this method applicable to recurrent blood sampling from small laboratory animals. Moreover, leukocyte enrichment is achieved within minutes and with low material efforts regarding chemicals and instrumentation, making this method applicable in multiple laboratory environments. Standardized purification of leukocytes is combined with a highly selective staining method to evaluate halogenating peroxidase activity of the heme peroxidases, myeloperoxidase (MPO) and eosinophil peroxidase (EPO), i.e., the formation of hypochlorous and hypobromous acid (HOCl and HOBr). While MPO is strongly expressed in neutrophils, the most abundant immune cell type in human blood as well as in monocytes, the related enzyme EPO is exclusively expressed in eosinophils. The halogenating activity of these enzymes is addressed by using the almost HOCl- and HOBr-specific dye aminophenyl fluorescein (APF) and the primary peroxidase substrate hydrogen peroxide. Upon subsequent flow cytometry analysis all peroxidase-positive cells (neutrophils, monocytes, eosinophils) are distinguishable and their halogenating peroxidase activity can be quantified. Since APF staining may be combined with the application of cell surface markers, this protocol can be extended to specifically address leukocyte sub-fractions. The method is applicable to detect HOCl and HOBr production both in human and in rodent leukocytes. Given the widely and diversely discussed immunological role of these enzymatic products in chronic inflammatory diseases, this protocol may contribute to a better understanding of the immunological relevance of leukocyte-derived heme peroxidases.


Asunto(s)
Leucocitos/enzimología , Peroxidasas/química , Animales , Peroxidasa del Eosinófilo/química , Humanos , Neutrófilos/enzimología
3.
PLoS One ; 11(3): e0152518, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27023113

RESUMEN

Rheumatoid arthritis (RA)--a widespread chronic inflammatory disease in industrialized countries--is characterized by a persistent and progressive joint destruction. The chronic pro-inflammatory state results from a mutual activation of the innate and the adaptive immune system, while the exact pathogenesis mechanism is still under discussion. New data suggest a role of the innate immune system and especially polymorphonuclear granulocytes (PMNs, neutrophils) not only during onset and the destructive phase of RA but also at the chronification of the disease. Thereby the enzymatic activity of myeloperoxidase (MPO), a peroxidase strongly abundant in neutrophils, may be important: While its peroxidase activity is known to contribute to cartilage destruction at later stages of RA the almost MPO-specific oxidant hypochlorous acid (HOCl) is also discussed for certain anti-inflammatory effects. In this study we used pristane-induced arthritis (PIA) in Dark Agouti rats as a model for the chronic course of RA in man. We were able to shown that a specific detection of the HOCl-producing MPO activity provides a sensitive new marker to evaluate the actual systemic inflammatory status which is only partially detectable by the evaluation of clinical symptoms (joint swelling and redness measurements). Moreover, we evaluated the long-term pharmacological effect of the well-known anti-inflammatory flavonoid epigallocatechin gallate (EGCG). Thereby only upon early and continuous oral application of this polyphenol the arthritic symptoms were considerably diminished both in the acute and in the chronic phase of the disease. The obtained results were comparable to the treatment control (application of methotrexate, MTX). As revealed by stopped-flow kinetic measurements, EGCG may regenerate the HOCl-production of MPO which is known to be impaired at chronic inflammatory diseases like RA. It can be speculated that this MPO activity-promoting effect of EGCG may contribute to the pharmacological mode of action of this polyphenol.


Asunto(s)
Artritis , Catequina , Animales , Femenino , Ratas , Artritis/sangre , Artritis/inducido químicamente , Artritis/tratamiento farmacológico , Biomarcadores/sangre , Catequina/análogos & derivados , Catequina/farmacología , Catequina/uso terapéutico , Enfermedad Crónica , Inflamación/sangre , Inflamación/patología , Metotrexato/uso terapéutico , Orosomucoide/metabolismo , Peroxidasa/sangre , Terpenos
4.
Sci Rep ; 5: 17845, 2015 Dec 08.
Artículo en Inglés | MEDLINE | ID: mdl-26644235

RESUMEN

Migraine animal models generally mimic the onset of attacks and acute treatment processes. A guinea pig model used the application of meta-chlorophenylpiperazine (mCPP) to trigger immediate dural plasma protein extravasation (PPE) mediated by 5-HT2B receptors. This model has predictive value for antimigraine drugs but cannot explain the delayed onset of efficacy of 5-HT2B receptor antagonists when clinically used for migraine prophylaxis. We found that mCPP failed to induce dural PPE in mice. Considering the role 5-HT2B receptors play in hypoxia-induced pulmonary vessel muscularization, we were encouraged to keep mice under hypoxic conditions and tested whether this treatment will render them susceptible to mCPP-induced dural PPE. Following four-week of hypoxia, PPE, associated with increased transendothelial transport, was induced by mCPP. The effect was blocked by sumatriptan. Chronic application of 5-HT2B receptor or nitric oxide synthase blockers during hypoxia prevented the development of susceptibility. Here we present a migraine model that distinguishes between a migraine-like state (hypoxic mice) and normal, normoxic mice and mimics processes that are related to chronic activation of 5-HT2B receptors under hypoxia. It seems striking, that chronic endogenous activation of 5-HT2B receptors is crucial for the sensitization since 5-HT2B receptor antagonists have strong, albeit delayed migraine prophylactic efficacy.


Asunto(s)
Proteínas Sanguíneas/metabolismo , Duramadre/metabolismo , Hipoxia/metabolismo , Trastornos Migrañosos/etiología , Trastornos Migrañosos/metabolismo , Animales , Modelos Animales de Enfermedad , Duramadre/irrigación sanguínea , Duramadre/efectos de los fármacos , Femenino , Cobayas , Masculino , Ratones , Óxido Nítrico Sintasa/metabolismo , Piperazinas/efectos adversos , Receptor de Serotonina 5-HT2B/metabolismo , Transcitosis , Remodelación Vascular
5.
J Immunol Methods ; 415: 46-56, 2014 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-25264081

RESUMEN

By combining easy and fast leukocyte enrichment with aminophenyl-fluorescein (APF) staining we developed a method to quickly and specifically address the halogenating activity of the immunological relevant blood heme peroxidases myeloperoxidase and eosinophil peroxidase, respectively. For leukocyte enrichment a two-fold hypotonic lysis procedure of the blood with Millipore water was chosen which represents a cheap, fast and reliable method to diminish the amount of erythrocytes in the samples. This procedure is shown to be suitable both to human and murine blood micro-samples, making it also applicable to small animal experiments with recurring blood sampling. As all types of leukocytes are kept in the sample during the preparation, they can be analysed separately after discrimination during the flow cytometry analysis. This also holds for all heme peroxidase-containing cells, namely neutrophils, eosinophils and monocytes. Moreover additional parameters (e.g. antibody staining) can be combined with the heme peroxidase activity determination to gain additional information about the different immune cell types. Based on previous results we applied APF for specifically addressing the halogenating activity of leukocyte peroxidases in blood samples. This dye is selectively oxidized by the MPO and EPO halogenation products hypochlorous and hypobromous acid. This approach may provide a suitable tool to gain more insights into the immune-physiological role of the halogenating activity of heme peroxidases.


Asunto(s)
Compuestos de Anilina/química , Asma/enzimología , Peroxidasa del Eosinófilo/sangre , Eosinófilos/enzimología , Fluoresceínas/química , Monocitos/enzimología , Neutrófilos/enzimología , Peroxidasa/sangre , Animales , Asma/inmunología , Asma/patología , Bromatos/química , Separación Celular , Modelos Animales de Enfermedad , Eosinófilos/inmunología , Eosinófilos/patología , Femenino , Citometría de Flujo , Halogenación , Humanos , Ácido Hipocloroso/química , Ratones , Ratones Endogámicos BALB C , Monocitos/inmunología , Monocitos/patología , Neutrófilos/inmunología , Neutrófilos/patología , Cultivo Primario de Células
6.
Naunyn Schmiedebergs Arch Pharmacol ; 379(6): 627-36, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19152053

RESUMEN

Cannabinoid receptor (CB) agonists are known to attenuate allodynia in a range of pain models, but their long-term effects and their mechanisms of action are controversial. The present study compares the antiallodynic effects of long-term treatment with a mixed CB1/CB2 (WIN55,212-2) and a selective CB2 (GW405833) cannabinoid receptor agonist and correlates these effects with their influences on spinal cord (SC) glial activation. The substances were applied daily in a rat neuropathic pain model. Tactile allodynia was assessed, and the development of gliosis was illustrated with immunohistochemical methods. Both substances reduced mechanical allodynia. Their analgesic effect was accompanied by a significant reduction in reactive gliosis and cathepsins (CAT) X and S expression. A daily injection of either substance for 8 days was sufficient to induce a sustained antiallodynic effect, which persisted up to 6 days after the last injection. The re-appearance of mechanical allodynia after this period was associated with a breakout of a strong gliotic response in the lumbar SC. Our results emphasize the therapeutic efficacy of cannabinoid receptor agonists and their inhibitory effects on the formation of gliosis.


Asunto(s)
Analgésicos/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Agonistas de Receptores de Cannabinoides , Modelos Animales de Enfermedad , Neuralgia/tratamiento farmacológico , Dolor/tratamiento farmacológico , Animales , Benzoxazinas/uso terapéutico , Cannabinoides/uso terapéutico , Indoles/farmacología , Indoles/uso terapéutico , Masculino , Morfolinas/farmacología , Morfolinas/uso terapéutico , Naftalenos/uso terapéutico , Neuralgia/patología , Dolor/patología , Ratas , Ratas Wistar , Receptores de Cannabinoides/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA